- Home
- FBP vs XENE Comparison
FBP vs XENE Comparison
Compare FBP & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBP
- XENE
- Stock Information
- Founded
- FBP 1948
- XENE 1996
- Country
- FBP United States
- XENE Canada
- Employees
- FBP N/A
- XENE N/A
- Industry
- FBP Major Banks
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- FBP Finance
- XENE Health Care
- Exchange
- FBP Nasdaq
- XENE Nasdaq
- Market Cap
- FBP 3.4B
- XENE 2.9B
- IPO Year
- FBP N/A
- XENE 2014
- Fundamental
- Price
- FBP $19.49
- XENE $41.92
- Analyst Decision
- FBP Buy
- XENE Strong Buy
- Analyst Count
- FBP 3
- XENE 10
- Target Price
- FBP $23.67
- XENE $53.00
- AVG Volume (30 Days)
- FBP 1.3M
- XENE 781.3K
- Earning Date
- FBP 10-23-2025
- XENE 11-03-2025
- Dividend Yield
- FBP 3.69%
- XENE N/A
- EPS Growth
- FBP 13.12
- XENE N/A
- EPS
- FBP 2.05
- XENE N/A
- Revenue
- FBP $902,789,000.00
- XENE $7,500,000.00
- Revenue This Year
- FBP $13.19
- XENE N/A
- Revenue Next Year
- FBP $5.73
- XENE $207.88
- P/E Ratio
- FBP $9.51
- XENE N/A
- Revenue Growth
- FBP 3.91
- XENE N/A
- 52 Week Low
- FBP $16.40
- XENE $26.74
- 52 Week High
- FBP $22.61
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- FBP 35.72
- XENE 56.45
- Support Level
- FBP $19.16
- XENE $40.79
- Resistance Level
- FBP $21.25
- XENE $42.96
- Average True Range (ATR)
- FBP 0.69
- XENE 1.50
- MACD
- FBP -0.16
- XENE -0.09
- Stochastic Oscillator
- FBP 10.73
- XENE 52.07
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.